$SMR

NuScale Power faces class action lawsuit alleging material misstatements about ENTRA1 partnership. Stock fell 12.4% post-disclosure; lead plaintiff deadline set for April 2026.

NuScale jumped 7.7% after Britain announced $805M in small modular reactor funding, though capital actually supports rival Rolls-Royce, raising questions about investor sentiment.

Securities lawsuit alleges NuScale Power made false statements about commercialization partner ENTRA1 Energy. Investors with $100K+ losses have until April 20, 2026 deadline.

AI data centers' surging power demands fuel $10 trillion nuclear opportunity. Oklo's small modular reactors edge NuScale's utility-scale focus for tech infrastructure needs.

NuScale Power's May 7, 2026 earnings could reveal major data center contracts, validating its $3.1B valuation as AI infrastructure drives nuclear energy demand.

NuScale Power stock down 30% since February miss; May 7 earnings expected to showcase TVA deal progress and data center customer conversions.

Fluor appoints SNC-Lavalin veteran Robert Card to board, signaling strategic focus on energy transition. Board changes alone unlikely to move stock without improved project execution.

NuScale Power swung 250% up then 80% down as analysts struggle with SMR valuations amid surging AI-driven electricity demand and decade-long development timelines.

Rivian and NuScale Power represent decade-long AI growth opportunities through autonomous vehicles and data center power, respectively, trading at discounts reflecting execution risks.

NuScale Power positioned to capitalize on nuclear renaissance driven by AI electricity demand, with Bank of America projecting $10 trillion market opportunity, though execution uncertainty remains significant.

NuScale Power faces securities class action alleging misrepresentations about strategic partner ENTRA1 Energy's nuclear experience. April 20, 2026 deadline applies.

Pomerantz Law Firm filed class action against $AMC over alleged securities fraud regarding APE preferred equity units excluded from special dividend. Investors must act by April 20, 2026.

Pomerantz Law Firm files class action against NuScale Power over undisclosed $495M payment to ENTRA1 Energy, causing 20% stock decline and $532M quarterly loss.

Pomerantz Law Firm filed class action against $QURE after 49% stock decline following FDA concerns over gene therapy study data adequacy.

PomDoctor stock plummeted 91% to $0.50 from $6.09 amid pump-and-dump fraud allegations. Pomerantz Law Firm filed class action; investors have until April 6, 2026 to claim losses.

Kyndryl Holdings faces 55% stock collapse after SEC financial reporting investigation and executive departures. Class action lawsuit filed; deadline April 13, 2026.

NuScale stock fell 15.6% in March after disappointing Q4 earnings, prompting analyst downgrades. Revenue declined 15% to $31.5M, but 2030 commercialization timeline remains on track.

Class action lawsuit filed against NuScale Power alleging false statements about partner ENTRA1's nuclear experience, claiming hundreds of millions at risk.

NuScale Power faces securities lawsuit alleging executives misrepresented partner ENTRA1 Energy's nuclear experience. Lead plaintiff deadline: April 20, 2026.

Law firms pursue class action lawsuits against Ostin Technology and NuScale Power over alleged securities fraud. Ostin investors lost 94% in single day; NuScale accused of misrepresenting partner credentials.